Production (Stage)
Tevogen Bio Holdings Inc.
TVGN
$1.31
$0.086.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -91.58% | 77.30% | 87.35% | 90.66% | 60.80% |
| Total Depreciation and Amortization | 6.51% | 6.63% | -15.35% | 2.80% | 26.10% |
| Total Amortization of Deferred Charges | -200.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 180.91% | -97.42% | -109.18% | -111.94% | -77.78% |
| Change in Net Operating Assets | -215.61% | -101.88% | 697.70% | 1,520.26% | 160.86% |
| Cash from Operations | -61.11% | -46.84% | -22.35% | 2.36% | 8.10% |
| Capital Expenditure | -- | -- | 100.00% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | 100.00% | 100.00% |
| Total Debt Issued | 100.00% | -75.00% | -78.05% | -70.00% | -80.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 300.00% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 279.56% | 250.80% | -- | -- |
| Cash from Financing | 263.01% | 215.81% | 79.02% | 32.03% | -49.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.08% | 105.20% | 91.59% | 49.14% | -129.81% |